No | Total no of clones analysed | Unique sequences/total | Preferential IgVH gene usage | Mutated/total (%) | Mutation mean (range) | IgVH rearrangements Ag selected/total | Ongoing mutation | Receptor revision |
1. | 22 | 9/22 | VH3 | 6/9 (67%) | 13.5 (3–20) | 2/9 | Yes | Yes |
2. | 18 | 16/18 | VH3(3–66) | 13/16 (81%) | 13 (5–23) | 9/25 | No | No |
3. | 31 | 29/31 | VH3(3–23) | 15/29 (52%) | 12.26 (5–29) | 6/29 | No | No |
4. | 38 | 25/38 | VH3(3–23) | 9/25 (36%) | 8.25 (4–13) | 6/25 | No | No |
5. | 38 | 29/38 | VH3(3–30) | 21/29 (73%) | 11.8 (7–22) | 9/29 | No | No |
6. | 36 | 31/36 | VH3(3–15) | 20/31 (65%) | 9.9 (3–29) | 9/31 | No | No |
IgVH, immunoglobulin variable heavy.